Vol. 18 - Num. 69
Childhood and Adolescence PrevInfad/PAPPS Group
José M.ª Mengual Gila, Manuel Merino Moínab, Carmen Rosa Pallás Alonsoc, Francisco Javier Sánchez Ruiz-Cabellod, Javier Soriano Faurae, Julia Colomer Revueltaf, Olga Cortés Ricog, M.ª Jesús Esparza Olcinah, Jaime García Aguadoh, Ana Martínez Rubioi, Grupo PrevInfad/PAPPS Infancia y Adolescenciaj
aPediatra. CS Delicias Sur. Zaragoza. España.
bPediatra. CS El Greco. Getafe. Madrid. España.
cServicio de Neonatología. Hospital Universitario 12 de Octubre. Madrid. España.
dPediatra. CS Zaidín Sur. Granada. España.
ePediatra. CS Fuensanta. Valencia. España.
fDepartamento de Pediatría, Obstetricia y Ginecología. Unidad de Pediatría. Universidad de Valencia. Valencia. España.
gPediatra. CS Canillejas. Madrid. España.
hPediatra. Madrid. España.
iPediatra. CS de Camas. Sevilla. España.
jJosé María Mengual Gil (coord.).
Correspondence: JM Mengual. E-mail: pepebobes@gmail.com
Reference of this article: Mengual Gil JM, Merino Moína M, Pallás Alonso CR, Sánchez Ruiz-Cabello FJ, Soriano Faura J, Colomer Revuelta J, et al. Tuberculosis screening. Rev Pediatr Aten Primaria. 2016;69:65-78.
Published in Internet: 29-03-2016 - Visits: 16908
Abstract
There is evidence that latent tuberculosis infection (LTBI) screening in low incidence areas, has a poor efficiency, many false positives and is not cost-effective. There is evidence that LTBI screening in groups at high risk of developing active tuberculosis infection (ATBI) improves the efficiency of the diagnostic tests as well as the risk-benefit balance and should take part of the strategies to reduce tuberculosis impact.
Tuberculin skin test is still the best performing diagnostic test in the screening for latent tuberculosis infection in children and adolescents.
PrevInfad recommendations (GRADE):
Keywords
● Interferon gamma release assays ● Latent Tuberculosis ● Mass screening ● Tuberculin skin testing ● Tuberculosis
Comments
This article has no comments yet.